Takeda Pharmaceutical Company Limited Net Income

Takeda Pharmaceutical Company Limited (TKPHF) currently reports a net income of $390B as of September 2026. That compares with $33B in the prior-year period — up 1069.8% year over year. That is above the Healthcare sector average of $72B. Use the charts on this page to explore Takeda Pharmaceutical Company Limited's net income history and peer comparisons.

Takeda Pharmaceutical Company Limited's net income increased from $33B to $390B — a 1069.8% year-over-year increase (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Takeda Pharmaceutical Company Limited's net income of $390B is higher than the Healthcare sector average of $72B. That is roughly 434.4% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Takeda Pharmaceutical Company Limited reported $390B in net income as of September 2026. That compares with $33B in the prior-year period — up 1069.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net income of $390B, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $72B. From there, open related valuation or income-statement pages for Takeda Pharmaceutical Company Limited, and consider following TKPHF for alerts when major investors trade the stock.